Randall L Hinrichs, MD in Lisbon, IA - Family Medicine

Randall L Hinrichs, MD is a Family Medicine physician based in Lisbon, Iowa. Randall L Hinrichs is licensed to practice in Iowa (license number 19432) and his current practice location is 23708 Cedar Jones Rd, Lisbon, Iowa. He can be reached at his office (for appointments etc.) via phone at (319) 350-0552.

NPI number for Randall L Hinrichs is 1922085612 and his current mailing address is 23708 Cedar Jones Rd, Lisbon, Iowa. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1922085612.

Contact Information

	Randall L Hinrichs, MD
	23708 Cedar Jones Rd, Lisbon, IA 52253-9027
	(319) 350-0552
	Not Available

Physician's Profile

Full Name	Randall L Hinrichs
Gender	Male
Speciality	Family Medicine
Location	23708 Cedar Jones Rd, Lisbon, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1922085612
Provider Enumeration Date: 12/23/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Randall L Hinrichs such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922085612	NPI	-	NPPES
0600791	Medicaid	IA
2305631	Medicaid	IA
26434	Other		WELLMARK OF IA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	19432 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Randall L Hinrichs is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Randall L Hinrichs, MD 23708 Cedar Jones Rd, Lisbon, IA 52253-9027 Ph: (319) 350-0552	Randall L Hinrichs, MD 23708 Cedar Jones Rd, Lisbon, IA 52253-9027 Ph: (319) 350-0552

News Archive

New effort in biomedical engineering may improve heart repair

Jianyi "Jay" Zhang, M.D., Ph.D., brought his biomedical engineering expertise to the University of Alabama at Birmingham to fix hearts.

Magnetic resonance ultrasound fusion biopsy may improve prostate cancer diagnosis

Diagnosis of prostate cancer remains imperfect. Current methods of prostate biopsy are limited by over detection of slow-growing tumors and under detection of clinically relevant cancers. Investigators at the University of California-Los Angeles Department of Urology have found that a new technique of targeted biopsy in a clinic setting, using local anesthesia, may improve diagnosis and aid in selecting which patients are suitable for active surveillance and which need focal therapy (noninvasive techniques for destroying small tumors within the prostate).

Astex celebrates as breast cancer drug gets European marketing approval

Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.

Researchers discover severe health consequences of folic acid deficiency

Researchers from the universities of Calgary and Cambridge, UK, have discovered that a mutation in a gene necessary for the metabolism of folic acid not only impacts immediate offspring but can also have detrimental health effects, such as spina bifida and heart abnormalities, on subsequent generations.

Randall L Hinrichs, MD - Family Medicine in Lisbon, IA